Researchers have developed nanorobotic agents that can navigate through the bloodstream to administer a drug by targeting the active cancerous cells of tumors.
Researchers have developed nanorobotic agents that can navigate through the bloodstream to administer a drug by targeting the active cancerous cells of tumors.